NOREL
Live / Registered — Registered (as of 17 Jun 2025)
What this means for you
Registered since 17 Jun 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Jun 2031: the §8 declaration of use).
Record
- Serial number
- 98930516
- Registration number
- 7836136
- Mark type
- Word mark
- Filed
- 31 Dec 2024
- Published for opposition
- 29 Apr 2025
- Registered
- 17 Jun 2025
- Next maintenance filing
- §8 declaration of use, due by 17 Jun 2031 (grace period to 17 Dec 2031)
- Attorney of record
- Joel R. Feldman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for sinus and allergy relief, for human consumption, not for animals
Owner
- U.S. Pharmaceutical Corporation, Decatur, GA, US
- U.S. Pharmaceutical Corporation, Decatur, GA, US
- U.S. Pharmaceutical Corporation, Decatur, GA, US
Prosecution history
- 17 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2025 — PUBLISHED FOR OPPOSITION
- 23 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
- 31 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 31 Mar 2025 — EXAMINERS AMENDMENT E-MAILED
- 31 Mar 2025 — EXAMINERS AMENDMENT -WRITTEN
- 31 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION E-MAILED
- 31 Mar 2025 — NON-FINAL ACTION WRITTEN
- 25 Mar 2025 — ASSIGNED TO EXAMINER
- 31 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED